Role of commercially available SARS-CoV-2 detection kits in pandemic of COVID-19 on the basis of N and E gene detection

Mubeen Khalid, Rani Wafa Shear, Wadiyat Rehman, Rahat Abdul Rehman, Babar Ali, Shahid Nazir, Muhammad Usman Basharat, Muhammad Farhan Khan


Coronavirus has blowout worldwide from the time when its revelation in Hubei Province, China in December 2019 introducing a genuine general wellbeing emergency. The capacity to recognize an irresistible specialist in a broad pestilence is vital to the achievement of isolate endeavors notwithstanding the delicate and precise screening of expected instances of disease from patients in a clinical setting. Structural proteins the basic key role-playing in SARS-CoV2 identification include a spike, envelope membrane, nucleocapsid, and helper proteins. N-protein ties to the infection single positive-strand RNA that permits the infection to assume control over human cells and transform them into infection industrial facilities inside the capsid and E-protein shows a significant part in infection gathering, film permeability of the host cell, and infection has cell correspondence. Nucleic-Acid base testing presently offers the most touchy and early discovery of COVID-19. Notwithstanding, analytic advancements have explicit impediments and announced a few false negative and false positive cases, particularly during the beginning phases of contamination. Presently, more refined diagnostics are being created to improve the COVID-19 determination. This article presents an outline of diagnostic approaches to address a few inquiries and issues identified with the constraints of flow innovations and future innovative work difficulties to empower ideal, fast, minimal effort, and precise analysis of arising irresistible illnesses We depict purpose of-care diagnostics that are not too far off and urge scholastics to propel their advancements past origination. Creating fitting and-play diagnostics to deal with the SARS-CoV-2 flare-up would be valuable in forestalling forthcoming pandemics.

Keywords: Role of commercially available kits; SARS-CoV2; Pandemic of Covid-19; N gene; E gene

Full Text:



Huang C, Wang Y, Li X, Ren L, Zhao J, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, (2020); 395(10223): 497-506.

Lu R, Zhao X, Li J, Niu P, Yang B, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet, (2020); 395(10224): 565-574.

Zhu N, Zhang D, Wang W, Li X, Yang B, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine, (2020).

Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt H-R, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New England journal of medicine, (2003); 348(20): 1967-1976.

Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New England Journal of Medicine, (2012); 367(19): 1814-1820.

Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, (2019); 17(3): 181-192.

Fan Y, Zhao K, Shi Z-L, Zhou P. Bat coronaviruses in China. Viruses, (2019); 11(3): 210.

Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology, (2018); 23(2): 130-137.

Peiris J, Lai S, Poon L, Guan Y, Yam L, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. The Lancet, (2003); 361(9366): 1319-1325.

Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature, (2020); 579(7798): 270-273.

Wu A, Peng Y, Huang B, Ding X, Wang X, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell host & microbe, (2020); 27(3): 325-328.

Sexton NR, Smith EC, Blanc H, Vignuzzi M, Peersen OB, et al. Homology-based identification of a mutation in the coronavirus RNA-dependent RNA polymerase that confers resistance to multiple mutagens. Journal of virology, (2016); 90(16): 7415-7428.

Luk HK, Li X, Fung J, Lau SK, Woo PC. Molecular epidemiology, evolution and phylogeny of SARS coronavirus. Infection, Genetics and Evolution, (2019); 7121-30.

Sarma P, Shekhar N, Prajapat M, Avti P, Kaur H, et al. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics, (2021); 39(8): 2724-2732.

Kirchdoerfer RN, Cottrell CA, Wang N, Pallesen J, Yassine HM, et al. Pre-fusion structure of a human coronavirus spike protein. Nature, (2016); 531(7592): 118-121.

Gupta MK, Vemula S, Donde R, Gouda G, Behera L, et al. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, (2021); 39(7): 2617-2627.

Corman V, Bleicker T, Brünink S, Drosten C, Zambon M. Diagnostic detection of 2019-nCoV by real-time RT-PCR. World Health Organization, (2020); 171-13.

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, (2020); 367(6483): 1260-1263.

Lambeir A-M, Durinx C, Scharpé S, De Meester I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Critical reviews in clinical laboratory sciences, (2003); 40(3): 209-294.

Zou L, Ruan F, Huang M, Liang L, Huang H, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England Journal of Medicine, (2020); 382(12): 1177-1179.

Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, et al. First case of 2019 novel coronavirus in the United States. New England Journal of Medicine, (2020).

Subissi L, Posthuma CC, Collet A, Zevenhoven-Dobbe JC, Gorbalenya AE, et al. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proceedings of the National Academy of Sciences, (2014); 111(37): E3900-E3909.

Wu F, Zhao S, Yu B, Chen Y-M, Wang W, et al. A new coronavirus associated with human respiratory disease in China. Nature, (2020); 579(7798): 265-269.

Miller S, Chiu C, Rodino KG, Miller MB. Point-counterpoint: should we be performing metagenomic next-generation sequencing for infectious disease diagnosis in the clinical laboratory? Journal of clinical microbiology, (2020); 58(3): e01739-01719.

Van Dijk EL, Auger H, Jaszczyszyn Y, Thermes C. Ten years of next-generation sequencing technology. Trends in genetics, (2014); 30(9): 418-426.

Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: pitfalls and potential. Biotechniques, (1999); 26(1): 112-125.

Corman V, Bleicker T, Brünink S, Drosten C, Landt O, et al. Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR. Geneva: World Health Organization, (2020); 13.

Wong ML, Medrano JF. Real-time PCR for mRNA quantitation. Biotechniques, (2005); 39(1): 75-85.

Chu DK, Pan Y, Cheng SM, Hui KP, Krishnan P, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clinical chemistry, (2020); 66(4): 549-555.

Craw P, Balachandran W. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. Lab on a Chip, (2012); 12(14): 2469-2486.

Lamb LE, Bartolone SN, Ward E, Chancellor MB. Rapid detection of novel coronavirus (COVID19) by reverse transcription-loop-mediated isothermal amplification. Available at SSRN 3539654, (2020).

Zhang Y, Odiwuor N, Xiong J, Sun L, Nyaruaba RO, et al. Rapid molecular detection of SARS-CoV-2 (COVID-19) virus RNA using colorimetric LAMP. MedRxiv, (2020).

Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, et al. Loop-mediated isothermal amplification of DNA. Nucleic acids research, (2000); 28(12): e63-e63.

Mori Y, Nagamine K, Tomita N, Notomi T. Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochemical and biophysical research communications, (2001); 289(1): 150-154.

Okamaoto K, Shirato K, Nao N, Saito S, Kageyama T, et al. An assessment of real-time RT-PCR kits for SARS-CoV-2 detection. Japanese journal of infectious diseases, (2020); JJID. 2020.2108.

Yip CC-Y, Sridhar S, Cheng AK-W, Leung K-H, Choi GK-Y, et al. Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection. Journal of Clinical Virology, (2020); 129104476.

Kuo L, Masters PS. The small envelope protein E is not essential for murine coronavirus replication. Journal of virology, (2003); 77(8): 4597-4608.

Maeda J, Repass JF, Maeda A, Makino S. Membrane topology of coronavirus E protein. Virology, (2001); 281(2): 163-169.

DeDiego ML, Álvarez E, Almazán F, Rejas MT, Lamirande E, et al. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. Journal of virology, (2007); 81(4): 1701-1713.

Regla-Nava JA, Nieto-Torres JL, Jimenez-Guardeño JM, Fernandez-Delgado R, Fett C, et al. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates. Journal of virology, (2015); 89(7): 3870-3887.


  • There are currently no refbacks.